Press Releases

 

General

  Date Title and Summary View
May 21, 2004
Columbia, MD - May 21, 2004: CELSION CORPORATION (AMEX: CLN) will hold its annual meeting on Tuesday, May 25, 2004 at 10:15 a.m. ET, with simultaneous webcast and telephone access. The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the ...
May 25, 2004
COLUMBIA, MD - May 25, 2004: CELSION CORPORATION (AMEX: CLN) announced today that it has received a warning letter from the Food and Drug Administration (the FDA) regarding the Phase I and Phase II clinical trials of its Prolieveā„¢ Thermodilatation system for the treatment of benign prostatic hyperplasia, or BPH. The FDA granted Premarketing Approv...
May 28, 2004
Columbia, MD - May 28, 2004: CELSION CORPORATION (AMEX: CLN) announced today that it has learned that its common stock has been listed on the Berlin-Bremen Stock Exchange without the Company's prior knowledge, consent or authorization. The Company, through its counsel, has contacted the Berlin-Bremen Stock Exchange and has demanded an i...
Jun 1, 2004
Columbia, MD - June 1, 2004: CELSION CORPORATION (AMEX: CLN) announced today that its response to the warning letter issued to it by the Food and Drug Administration (FDA) on May 7, 2004 was submitted to the FDA on Friday, May 28, 2004. As previously announced, the warning letter reflected certain matters that arose in connection with the Phase I ...
Aug 31, 2004
COLUMBIA, Md.--(BUSINESS WIRE)--Aug. 31, 2004--CELSION CORPORATION (AMEX:CLN) today announced that the Food and Drug Administration (FDA) will allow the human clinical trial for its investigational therapy for the treatment of liver cancer to proceed. The Phase I study will investigate the use of Celsion's proprietary product, ThermoDox...
Sep 8, 2004
COLUMBIA, Md.--(BUSINESS WIRE)--Sept. 8, 2004--CELSION CORPORATION (AMEX:CLN) today announced that, upon the recommendation of its Nominating Committee, effective September 7, 2004, its Board of Directors has acted to increase from five to six the number of directors constituting the whole Board of Directors and to fill the resulting vacancy b...
Sep 13, 2004
COLUMBIA, Md.--(BUSINESS WIRE)--Sept. 13, 2004--CELSION CORPORATION (AMEX:CLN) today announced the resignation of Dr. William E. Gannon, as the Company's Vice President--Clinical Affairs and Medical Director. Dr. Gannon has served in those positions since January 2002. According to Dr. Augustine Cheung, Celsion's President and Chief...
Sep 13, 2004
COLUMBIA, Md.--(BUSINESS WIRE)--Sept. 13, 2004--CELSION CORPORATION (AMEX:CLN) today announced that its 2005 Annual Meeting of Stockholders will be held on Thursday, May 19, 2005 at 10 o'clock a.m. Eastern Time in Columbia, Maryland. The venue and record date for the Meeting, as well as the items to be acted upon, will be determined at a later...
Sep 13, 2004
COLUMBIA, Md., Sep 13, 2004 (BUSINESS WIRE) -- CELSION CORPORATION (AMEX:CLN) announced the following webcast: What: CLN Presentation at RedChip Resources Discovery Day Conference St. Regis Hotel, New York City When: September 15, 2004 at 10:00 a.m. EST in Louis XVI, Room A Where: http://www.w
Oct 21, 2004
COLUMBIA, Md.--(BUSINESS WIRE)--Oct. 21, 2004--CELSION CORPORATION (AMEX:CLN) announced that its Executive Vice President and Chief Operating Officer, Tony Deasey, is scheduled to appear as a featured presenter at the Rodman & Renshaw Techvest 6th Annual Healthcare Conference taking place October 26-28, 2004, in New York, New York. His pre...
Page:
1
... NextLast
= add release to Briefcase
Share This